1. ScholarBank@NUS

ZHOU JIANBIAO

rp08177

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
ZHOU JIANBIAO
Variants
Zhou, J.
Zhou, J.B.
Zhou J
Zhou, Jianbiao
 
Main Affiliation
 
Faculty
 

Publications

Results 1-17 of 17 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
1Mar-2011Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profilingNg, S.-B.; Selvarajan, V.; Huang, G. ; Zhou, J. ; Feldman, A.L.; Law, M.; Kwong, Y.-L.; Shimizu, N.; Kagami, Y.; Aozasa, K.; Salto-Tellez, M. ; Chng, W.-J.
214-Jul-2011Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-B: Implication in breast cancer metastasisBist, P.; Leow, S.C.; Phua, Q.H.; Shu, S.; Zhuang, Q.; Loh, W.T.; Nguyen, T.H.; Zhou, J.B. ; Hooi, S.C.; Lim, L.H.K.
32011Determinants of sensitivity to DZNep induced Apoptosis in multiple myeloma cellsXie, Z. ; Bi, C.; Cheong, L.L.; Liu, S.C.; Huang, G. ; Zhou, J. ; Yu, Q.; Chen, C.-S.; Chng, W.J.
4Feb-2012Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in miceGuo, K.; Tang, J.P.; Jie, L.; Al-Aidaroos, A.Q.O.; Hong, C.W.; Tan, C.P.B.; Park, J.E.; Varghese, L.; Feng, Z.; Zhou, J. ; Chng, W.J.; Zeng, Q. 
52015Functional characterization of D9, a novel deazaneplanocin a (DZNep) analog, in targeting acute myeloid leukemia (AML)Jiang, Xia; Lim, Cheryl Zi Hui; Li, Zhimei; Lee, Puayleng; Yatim, Siti Maryam J. M.; Guan, Peiyong; Li, Juntao; Zhou, Jianbiao ; Pan, Jingxuan; Chng, Wee Joo ; Chai, Li Lin Christina ; Yu, Qiang 
6May-2013LIN28/LIN28B: An emerging oncogenic driver in cancer stem cellsZhou, J. ; Ng, S.-B.; Chng, W.-J.
7Sep-2013Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemiaPark, J.E.; Yuen, H.F.; Zhou, J.B. ; Al-aidaroos, A.Q.O.; Guo, K.; Valk, P.J.; Zhang, S.D.; Chng, W.J.; Hong, C.W.; Mills, K.; Zeng, Q. 
82015P53 mutations in colorectal cancer- Molecular pathogenesis and pharmacological reactivationLi X.-L; Zhou J ; Chen Z.-R; Chng W.J 
9Nov-2011Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemiaHart, S.; Goh, K.C.; Novotny-Diermayr, V.; Tan, Y.C.; Madan, B.; Amalini, C.; Ong, L.C.; Kheng, B.; Cheong, A.; Zhou, J. ; Chng, W.J.; Wood, J.M.
102011PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-aml therapyZhou, J. ; Bi, C.; Chng, W.-J.; Cheong, L.-L.; Liu, S.-C.; Mahara, S. ; Tay, K.-G. ; Zeng, Q.; Li, J.; Guo, K.; Tan, C.P.B.; Yu, H. ; Albert, D.H.; Chen, C.-S.
11Sep-2010Pulse-modulated second harmonic imaging microscope quantitatively demonstrates marked increase of collagen in tumor after chemotherapyRaja, A.M.; Xu, S.; Sun, W.; Zhou, J. ; Tai, D.C.S.; Chen, C.-S.; Rajapakse, J.C.; So, P.T.C.; Yu, H. 
1216-Jun-2010Reduced plasma APOA1 level is associated with Gastric Tumor Growth in MKN45 mouse xenograft modelChong, P.-K. ; Lee, H. ; Zhou, J. ; Liu, S.-C.; Loh, M.C.S. ; So, J.B.Y.; Lim, K.H.; Yeoh, K.-G.; Lim, Y.-P. 
13May-2013Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancerZhou, J. ; Chng, W.-J.
14Jan-2008Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathwayZhou, J. ; Pan, M.; Xie, Z. ; Loh, S.-L.; Bi, C.; Tai, Y.-C.; Lilly, M.; Lim, Y.-P. ; Han, J.-H.; Glaser, K.B.; Albert, D.H.; Davidsen, S.K.; Chen, C.-S.
152011The slow-releasing Hydrogen Sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivoLee, Z.W.; Zhou, J. ; Chen, C.-S.; Zhao, Y. ; Tan, C.-H. ; Li, L.; Moore, P.K.; Deng, L.-W.
16Feb-2011Therapeutic potential of antisense oligodeoxynucleotides in downregulating p53 oncogenic mutations in cancersXie, Z. ; Chng, W.J.; Tay, K.G. ; Liu, S.C.; Zhou, J. ; Chen, C.-S.
17Dec-2011TXNIP (VDUP-1, TBP-2): A major redox regulator commonly suppressed in cancer by epigenetic mechanismsZhou, J. ; Yu, Q.; Chng, W.-J.